{"id":"https://openalex.org/W1574255477","doi":"https://doi.org/10.1158/1538-7445.sabcs14-p4-01-21","title":"Abstract P4-01-21: Analysis and single-cell retrieval of circulating tumor cells to monitor treatment response and assess genotype in triple-negative breast cancer","display_name":"Abstract P4-01-21: Analysis and single-cell retrieval of circulating tumor cells to monitor treatment response and assess genotype in triple-negative breast cancer","publication_year":2015,"publication_date":"2015-05-01","ids":{"openalex":"https://openalex.org/W1574255477","doi":"https://doi.org/10.1158/1538-7445.sabcs14-p4-01-21","mag":"1574255477"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.sabcs14-p4-01-21","doi":"https://doi.org/10.1158/1538-7445.sabcs14-p4-01-21","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs14-p4-01-21","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112840706","display_name":"Arturo B. Ramirez","orcid":"https://orcid.org/0000-0001-8528-2569","observed_orcids":["https://orcid.org/0000-0001-8528-2569"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Arturo Ramirez","raw_affiliation_strings":["1RareCyte, Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1RareCyte, Inc","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061988337","display_name":"Daniel E. Campton","orcid":"https://orcid.org/0000-0001-6878-3599","observed_orcids":["https://orcid.org/0000-0001-6878-3599"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel Campton","raw_affiliation_strings":["1RareCyte, Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1RareCyte, Inc","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074853748","display_name":"Elisabeth M. Mahen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elisabeth Mahen","raw_affiliation_strings":["2Center for Cancer Innovation, University of Washington"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Center for Cancer Innovation, University of Washington","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070081606","display_name":"Sibel H. Blau","orcid":"https://orcid.org/0000-0002-5249-1521","observed_orcids":["https://orcid.org/0000-0002-5249-1521"]},"institutions":[{"id":"https://openalex.org/I4210149734","display_name":"Northwest Medical Specialties","ror":"https://ror.org/05hr4m393","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210149734"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sibel Blau","raw_affiliation_strings":["3Northwest Medical Specialties"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Northwest Medical Specialties","institution_ids":["https://openalex.org/I4210149734"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016190793","display_name":"Anthony Blau","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anthony Blau","raw_affiliation_strings":["2Center for Cancer Innovation, University of Washington"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Center for Cancer Innovation, University of Washington","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010999026","display_name":"Eric Peter Kaldjian","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eric Kaldjian","raw_affiliation_strings":["1RareCyte, Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1RareCyte, Inc","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5060779623","display_name":"Jackie L. Stilwell","orcid":"https://orcid.org/0009-0002-3789-2412","observed_orcids":["https://orcid.org/0009-0002-3789-2412"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jackie Stilwell","raw_affiliation_strings":["1RareCyte, Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1RareCyte, Inc","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"75","issue":"9_Supplement","first_page":"P4","last_page":"01"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.9868000149726868,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.9868000149726868,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","score":0.006800000090152025,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/circulating-tumor-cells","display_name":"circulating tumor cells","score":0.9710000157356262},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":1.0},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.7580000162124634},{"id":"https://openalex.org/keywords/treatment-response-monitoring","display_name":"treatment response monitoring","score":0.8149999976158142},{"id":"https://openalex.org/keywords/ros1-mutation","display_name":"ROS1 mutation","score":0.875},{"id":"https://openalex.org/keywords/crizotinib","display_name":"crizotinib","score":0.8769999742507935},{"id":"https://openalex.org/keywords/somatic-mutations","display_name":"somatic mutations","score":0.4699999988079071},{"id":"https://openalex.org/keywords/ctc-enrichment","display_name":"CTC enrichment","score":0.4410000145435333},{"id":"https://openalex.org/keywords/liquid-biopsy","display_name":"liquid biopsy","score":0.531000018119812},{"id":"https://openalex.org/keywords/disease-progression","display_name":"disease progression","score":0.5619999766349792},{"id":"https://openalex.org/keywords/ki-67","display_name":"Ki-67","score":0.7609999775886536},{"id":"https://openalex.org/keywords/epcam","display_name":"EpCAM","score":0.4480000138282776},{"id":"https://openalex.org/keywords/her2","display_name":"HER2","score":0.5080000162124634},{"id":"https://openalex.org/keywords/egfr","display_name":"EGFR","score":0.9959999918937683},{"id":"https://openalex.org/keywords/whole-genome-amplification","display_name":"whole genome amplification","score":0.4819999933242798}],"concepts":[{"id":"https://openalex.org/C61238886","wikidata":"https://www.wikidata.org/wiki/Q5121689","display_name":"Circulating tumor cell","level":4,"score":0.8494287133216858},{"id":"https://openalex.org/C2780110267","wikidata":"https://www.wikidata.org/wiki/Q7843332","display_name":"Triple-negative breast cancer","level":4,"score":0.601377546787262},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5921164751052856},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.561767578125},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5585137009620667},{"id":"https://openalex.org/C2779012181","wikidata":"https://www.wikidata.org/wiki/Q2750567","display_name":"Cytokeratin","level":3,"score":0.5288684964179993},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.5145625472068787},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.4433746933937073},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4407913088798523},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.4364608824253082},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.35099732875823975},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.3288899064064026},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.30615657567977905},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.18337443470954895}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.sabcs14-p4-01-21","doi":"https://doi.org/10.1158/1538-7445.sabcs14-p4-01-21","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs14-p4-01-21","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Industry, innovation and infrastructure","score":0.5099999904632568,"id":"https://metadata.un.org/sdg/9"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2185024368","https://openalex.org/W2907367421","https://openalex.org/W2739526444","https://openalex.org/W2566239891","https://openalex.org/W2138761091","https://openalex.org/W2135705453","https://openalex.org/W2343095581","https://openalex.org/W4286298172","https://openalex.org/W2113756065","https://openalex.org/W2159232758"],"abstract_inverted_index":{"Abstract":[0],"Introduction:":[1],"We":[2],"used":[3,203],"a":[4,43,158,174,363,435],"high-recovery":[5],"rare":[6],"cell":[7],"analysis":[8,24,75,109,183],"and":[9,16,59,71,122,137,144,155,157,177,191,195,210,244,258,316,335,337,377,419,441,465,485,496],"single-cell":[10,73,486],"picking":[11],"system":[12,243],"to":[13,45,55,76,120,146,152,163,204,215,217,267,300,309,333,341,371,393,426,492],"enrich,":[14],"visualize,":[15],"isolate":[17],"circulating":[18,489],"tumor":[19,446,490],"cells":[20,129,141,206,227,319,447,491],"(CTCs)":[21],"for":[22,94,100,246],"genomic":[23],"from":[25,229],"the":[26,86,89,133,218,225,230,247,283,286,382,408,442,507],"blood":[27,128],"of":[28,42,91,104,110,113,127,193,220,233,355,375,410,431,438,445,488,506],"patients":[29,263,449],"with":[30,38,65,285,325,361,381,401,450,461],"advanced":[31],"triple-negative":[32,500],"breast":[33,501],"cancer":[34,226,439,502],"(TNBC)":[35],"undergoing":[36],"treatment":[37,54,66,121,360,391,494],"cisplatin":[39,326],"as":[40],"part":[41],"study":[44,87],"intensively":[46],"characterize":[47,205],"TNBC.":[48,451],"CTCs":[49,116,179,185,236,358,424,432],"were":[50,83,117,142,161,171,186,237,289],"evaluated":[51,118,245],"regularly":[52],"during":[53,322,389],"monitor":[56,493],"CTC":[57,280,297,304,314,338,386,453],"burden":[58],"characteristics":[60],"that":[61],"could":[62],"be":[63],"associated":[64],"response":[67,495],"or":[68],"disease":[69],"progression,":[70,336],"perform":[72],"mutational":[74],"inform":[77],"clinical":[78],"decision":[79],"making.":[80],"Methods:":[81],"Patients":[82],"enrolled":[84,266],"in":[85,102,224,276,282,329,352,448,499],"at":[88],"University":[90],"Washington":[92],"Center":[93],"Cancer":[95,514,525],"Innovation":[96],"after":[97,295,311,455],"informed":[98],"consent":[99],"participation":[101],"investigation":[103],"their":[105],"disease,":[106],"including":[107],"molecular":[108,443],"multiple":[111],"biopsies":[112],"accessible":[114],"tumor.":[115],"prior":[119],"tracked":[123],"longitudinally.":[124],"Density-based":[125],"enrichment":[126],"was":[130,222,327,350,369,378,398],"performed":[131],"using":[132,165,181,239,250],"AccuCyte":[134],"tube,":[135],"float":[136],"collector":[138],"system.":[139],"Collected":[140],"processed":[143],"applied":[145,162],"microscopic":[147],"slides.":[148],"Fluorescently":[149],"labeled":[150],"antibodies":[151,202],"cytokeratin,":[153],"CD45":[154,199],"EpCAM,":[156],"nuclear":[159,196],"dye":[160],"samples":[164],"an":[166,403],"automated":[167],"slide":[168],"stainer.":[169],"Slides":[170],"scanned":[172],"on":[173,407],"digital":[175],"microscope":[176],"candidate":[178],"identified":[180,223],"image":[182],"software.":[184],"verified":[187],"by":[188,255],"appropriate":[189],"morphology":[190],"expression":[192],"epithelial":[194],"stains":[197],"without":[198],"expression.":[200],"Other":[201],"included":[207],"Her2,":[208],"EGFR,":[209],"Ki-67.":[211],"A":[212,366],"mutation":[213,288,349],"hypothesized":[214],"lead":[216],"activation":[219],"ROS1":[221,248,287,348,364],"isolated":[228],"bone":[231],"marrow":[232],"one":[234],"patient.":[235],"picked":[238,357],"our":[240],"integrated":[241],"semi-automated":[242],"variant":[249],"whole":[251,462],"genome":[252,463],"amplification":[253,464],"followed":[254],"nested":[256],"PCR":[257],"Sanger":[259],"sequencing.":[260],"Results:":[261],"Seven":[262],"have":[264,372],"been":[265,274],"date.":[268],"At":[269],"least":[270],"1":[271],"CTC/mL":[272],"has":[273],"found":[275,351,370],"all":[277],"patients.":[278],"Pre-treatment":[279],"levels":[281,298,339,387],"patient":[284,331,368,397],"extremely":[290],"high":[291],"(1500/mL).":[292],"One":[293],"week":[294],"treatment,":[296],"spiked":[299],"more":[301],"than":[302],"5000/mL.":[303],"counts":[305],"then":[306],"dropped":[307],"exponentially":[308],"9/mL":[310],"4":[312,345],"months.":[313,346],"clusters":[315],"Ki-67":[317],"positive":[318],"also":[320],"decreased":[321],"therapy.":[323],"Treatment":[324],"discontinued":[328],"this":[330],"due":[332],"toxicity":[334],"increased":[340,388],"nearly":[342],"9000/mL":[343],"over":[344],"The":[347,395],"approximately":[353],"50%":[354],"individually":[356],"before":[359],"crizotinib,":[362],"inhibitor.":[365],"second":[367],"somatic":[373,413],"loss":[374],"BRCA1,":[376],"therefore":[379],"treated":[380,400],"PARP":[383],"inhibitor,":[384,405],"veliparib.":[385],"veliparib":[390],"up":[392],"13/mL.":[394],"same":[396],"subsequently":[399],"ponatinib,":[402,423],"FGFR":[404],"based":[406],"identification":[409],"two":[411],"linked":[412],"missense":[414],"mutations":[415],"involving":[416],"FGFR2":[417],"(S252W":[418],"Y375C).":[420],"After":[421],"beginning":[422],"fell":[425],"undetectable":[427],"levels.":[428],"Conclusions:":[429],"Analysis":[430,484],"may":[433],"provide":[434],"non-invasive":[436],"measure":[437],"progression/response":[440],"evolution":[444],"Single-cell":[452],"retrieval":[454,487],"slide-based":[456],"immunofluorescent":[457],"visualization":[458],"is":[459],"compatible":[460],"sequencing":[466],"methods.":[467],"Citation":[468],"Format:":[469],"Arturo":[470],"Ramirez,":[471],"Daniel":[472],"Campton,":[473],"Elisabeth":[474],"Mahen,":[475],"Sibel":[476],"Blau,":[477,479],"Anthony":[478],"Eric":[480],"Kaldjian,":[481],"Jackie":[482],"Stilwell.":[483],"assess":[497],"genotype":[498],"[abstract].":[503],"In:":[504],"Proceedings":[505],"Thirty-Seventh":[508],"Annual":[509],"CTRC-AACR":[510],"San":[511,519],"Antonio":[512],"Breast":[513],"Symposium:":[515],"2014":[516],"Dec":[517],"9-13;":[518],"Antonio,":[520],"TX.":[521],"Philadelphia":[522],"(PA):":[523],"AACR;":[524],"Res":[526],"2015;75(9":[527],"Suppl):Abstract":[528],"nr":[529],"P4-01-21.":[530]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2016-06-24T00:00:00"}